Page last updated: 2024-10-21

7-nitroindazole and Autosomal Recessive Chronic Granulomatous Disease

7-nitroindazole has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies

7-nitroindazole: an inhibitor of nitric oxide synthase; exhibits anti-nociceptive activity without increasing blood pressure

Research Excerpts

ExcerptRelevanceReference
" In these patients, the prophylactic and therapeutic validity of a long-term use of trimethoprim-sulfamethoxazole (TMP-SMX) has been well established."1.31Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole. ( Hasui, M; Kobayashi, Y; Taniuchi, S; Tsuji, S; Yamamoto, A, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuji, S1
Taniuchi, S1
Hasui, M1
Yamamoto, A1
Kobayashi, Y1

Other Studies

1 other study available for 7-nitroindazole and Autosomal Recessive Chronic Granulomatous Disease

ArticleYear
Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole.
    Nitric oxide : biology and chemistry, 2002, Volume: 7, Issue:4

    Topics: Adolescent; Adult; Anti-Infective Agents; Calcimycin; Child; Child, Preschool; Enzyme Inhibitors; Fl

2002